TTM
$55.42M
YoY change
+42.9%
5Y CAGR
+58.4%
Peak year (2025)
$60.10M
Cumulative gross profit
$198.54M
Gross Profit history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: $60.10M
Gross Profit growth chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +42.9%
Gross Profit history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | $60.10M | +42.9% | +$18.03M | ||
| 2024 | $42.07M | +15.2% | +$5.54M | ||
| 2023 | $36.53M | +46.9% | +$11.67M | ||
| 2022 | $24.86M | -32.9% | −$12.18M | ||
| 2021 | $37.04M | +514.2% | +$31.01M | ||
| 2020 | $6.03M | -179.1% | +$13.66M | ||
| 2019 | −$7.63M | — | — |
- 2025$60.10M+42.9%
- 2024$42.07M+15.2%
- 2023$36.53M+46.9%
- 2022$24.86M-32.9%
- 2021$37.04M+514.2%
- 2020$6.03M-179.1%
- 2019−$7.63M—
Gross Profit values are taken from Tango Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's current gross profit (TTM) is $55.42M. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Tango Therapeutics (TNGX) gross profit totalled $60.10M – surged 42.9% year-over-year.
Over 2020–2025 (5 years), Tango Therapeutics gross profit expanded at a +58.4% compound annual rate, sustaining 3 straight years of year-over-year growth.
The highest annual gross profit of $60.10M was reported in 2025. The lowest in the available history was −$7.63M in 2019.
Tango Therapeutics Gross Profit by Year
Tango Therapeutics Gross Profit 2025: $60.10M
Tango Therapeutics posted gross profit of $60.10M in 2025, surged 42.9% from 2024. This figure represents the highest annual value in the available history.
Tango Therapeutics Gross Profit 2024: $42.07M
In 2024, Tango Therapeutics reported gross profit of $42.07M, grew 15.2% from 2023.
Tango Therapeutics Gross Profit 2023: $36.53M
Tango Therapeutics gross profit in 2023 was $36.53M, surged 46.9% from 2022.
Tango Therapeutics Gross Profit 2022: $24.86M
2022's gross profit for Tango Therapeutics came in at $24.86M, plunged 32.9% below 2021.
Tango Therapeutics Gross Profit 2021: $37.04M
Tango Therapeutics gross profit in 2021 was $37.04M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Gross Profit
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation